0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Othe-2O272
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027

Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027

Code: QYRE-Othe-2O272
Report
July 2021
120 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Market Analysis and Insights: Global Infectious Disease Diagnostics Testing Market
The global Infectious Disease Diagnostics Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Diagnostics Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Diagnostics Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Diagnostics Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Diagnostics Testing market.
Global Infectious Disease Diagnostics Testing Scope and Market Size
Infectious Disease Diagnostics Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Diagnostics Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test

Segment by Application

Hospital
Academics Research
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Abbott
bioMérieux
Diasorin
Roche Diagnostic
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostics Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Academics Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2016-2027)
2.2 Infectious Disease Diagnostics Testing Growth Trends by Regions
2.2.1 Infectious Disease Diagnostics Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Diagnostics Testing Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Diagnostics Testing Industry Dynamic
2.3.1 Infectious Disease Diagnostics Testing Market Trends
2.3.2 Infectious Disease Diagnostics Testing Market Drivers
2.3.3 Infectious Disease Diagnostics Testing Market Challenges
2.3.4 Infectious Disease Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Diagnostics Testing Revenue
3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2020
3.5 Infectious Disease Diagnostics Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Diagnostics Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Diagnostics Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostics Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2022-2027)
5 Infectious Disease Diagnostics Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Disease Diagnostics Testing Market Size (2016-2027)
6.2 North America Infectious Disease Diagnostics Testing Market Size by Type
6.2.1 North America Infectious Disease Diagnostics Testing Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Diagnostics Testing Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Diagnostics Testing Market Size by Type (2016-2027)
6.3 North America Infectious Disease Diagnostics Testing Market Size by Application
6.3.1 North America Infectious Disease Diagnostics Testing Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Diagnostics Testing Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Diagnostics Testing Market Size by Application (2016-2027)
6.4 North America Infectious Disease Diagnostics Testing Market Size by Country
6.4.1 North America Infectious Disease Diagnostics Testing Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Diagnostics Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Testing Market Size (2016-2027)
7.2 Europe Infectious Disease Diagnostics Testing Market Size by Type
7.2.1 Europe Infectious Disease Diagnostics Testing Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Diagnostics Testing Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Diagnostics Testing Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Diagnostics Testing Market Size by Application
7.3.1 Europe Infectious Disease Diagnostics Testing Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Diagnostics Testing Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Diagnostics Testing Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Diagnostics Testing Market Size by Country
7.4.1 Europe Infectious Disease Diagnostics Testing Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Testing Market Size (2016-2027)
9.2 Latin America Infectious Disease Diagnostics Testing Market Size by Type
9.2.1 Latin America Infectious Disease Diagnostics Testing Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Diagnostics Testing Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Diagnostics Testing Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Diagnostics Testing Market Size by Application
9.3.1 Latin America Infectious Disease Diagnostics Testing Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Diagnostics Testing Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Diagnostics Testing Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Diagnostics Testing Market Size by Country
9.4.1 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Details
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Infectious Disease Diagnostics Testing Introduction
11.2.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.2.5 bioMérieux Recent Development
11.3 Diasorin
11.3.1 Diasorin Company Details
11.3.2 Diasorin Business Overview
11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction
11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.3.5 Diasorin Recent Development
11.4 Roche Diagnostic
11.4.1 Roche Diagnostic Company Details
11.4.2 Roche Diagnostic Business Overview
11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction
11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.4.5 Roche Diagnostic Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction
11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction
11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Cavidi
11.8.1 Cavidi Company Details
11.8.2 Cavidi Business Overview
11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction
11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.8.5 Cavidi Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction
11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.9.5 Cepheid Recent Development
11.10 Corgenix
11.10.1 Corgenix Company Details
11.10.2 Corgenix Business Overview
11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction
11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.10.5 Corgenix Recent Development
11.11 Diaxonhit
11.11.1 Diaxonhit Company Details
11.11.2 Diaxonhit Business Overview
11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction
11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.11.5 Diaxonhit Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction
11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.12.5 Eiken Chemical Recent Development
11.13 EMD Millipore
11.13.1 EMD Millipore Company Details
11.13.2 EMD Millipore Business Overview
11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction
11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.13.5 EMD Millipore Recent Development
11.14 Epitope Diagnostic
11.14.1 Epitope Diagnostic Company Details
11.14.2 Epitope Diagnostic Business Overview
11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction
11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.14.5 Epitope Diagnostic Recent Development
11.15 EUROIMMUN
11.15.1 EUROIMMUN Company Details
11.15.2 EUROIMMUN Business Overview
11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction
11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.15.5 EUROIMMUN Recent Development
11.16 Gold Standard Diagnostics
11.16.1 Gold Standard Diagnostics Company Details
11.16.2 Gold Standard Diagnostics Business Overview
11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction
11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.16.5 Gold Standard Diagnostics Recent Development
11.17 Hologic
11.17.1 Hologic Company Details
11.17.2 Hologic Business Overview
11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction
11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.17.5 Hologic Recent Development
11.18 Immunetics
11.18.1 Immunetics Company Details
11.18.2 Immunetics Business Overview
11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction
11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
11.18.5 Immunetics Recent Development
11.18 InBios International
.1 InBios International Company Details
.2 InBios International Business Overview
.3 InBios International Infectious Disease Diagnostics Testing Introduction
.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2016-2021)
.5 InBios International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Molecular Diagnostic Test
    Table 3. Key Players of POC Infectious Disease Diagnostics Test
    Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Infectious Disease Diagnostics Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Infectious Disease Diagnostics Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Infectious Disease Diagnostics Testing Market Share by Regions (2016-2021)
    Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Infectious Disease Diagnostics Testing Market Share by Regions (2022-2027)
    Table 10. Infectious Disease Diagnostics Testing Market Trends
    Table 11. Infectious Disease Diagnostics Testing Market Drivers
    Table 12. Infectious Disease Diagnostics Testing Market Challenges
    Table 13. Infectious Disease Diagnostics Testing Market Restraints
    Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Infectious Disease Diagnostics Testing Market Share by Players (2016-2021)
    Table 16. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Diagnostics Testing as of 2020)
    Table 17. Ranking of Global Top Infectious Disease Diagnostics Testing Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Infectious Disease Diagnostics Testing Product Solution and Service
    Table 21. Date of Enter into Infectious Disease Diagnostics Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2016-2021)
    Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Infectious Disease Diagnostics Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2016-2021)
    Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Infectious Disease Diagnostics Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Infectious Disease Diagnostics Testing Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Infectious Disease Diagnostics Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Infectious Disease Diagnostics Testing Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Infectious Disease Diagnostics Testing Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Infectious Disease Diagnostics Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Infectious Disease Diagnostics Testing Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Infectious Disease Diagnostics Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Infectious Disease Diagnostics Testing Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Infectious Disease Diagnostics Testing Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Infectious Disease Diagnostics Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Infectious Disease Diagnostics Testing Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Infectious Disease Diagnostics Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Abbott Company Details
    Table 62. Abbott Business Overview
    Table 63. Abbott Infectious Disease Diagnostics Testing Product
    Table 64. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 65. Abbott Recent Development
    Table 66. bioMérieux Company Details
    Table 67. bioMérieux Business Overview
    Table 68. bioMérieux Infectious Disease Diagnostics Testing Product
    Table 69. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 70. bioMérieux Recent Development
    Table 71. Diasorin Company Details
    Table 72. Diasorin Business Overview
    Table 73. Diasorin Infectious Disease Diagnostics Testing Product
    Table 74. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 75. Diasorin Recent Development
    Table 76. Roche Diagnostic Company Details
    Table 77. Roche Diagnostic Business Overview
    Table 78. Roche Diagnostic Infectious Disease Diagnostics Testing Product
    Table 79. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 80. Roche Diagnostic Recent Development
    Table 81. Beckman Coulter Company Details
    Table 82. Beckman Coulter Business Overview
    Table 83. Beckman Coulter Infectious Disease Diagnostics Testing Product
    Table 84. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 85. Beckman Coulter Recent Development
    Table 86. Becton, Dickinson and Company Company Details
    Table 87. Becton, Dickinson and Company Business Overview
    Table 88. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product
    Table 89. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 90. Becton, Dickinson and Company Recent Development
    Table 91. Bio-Rad Laboratories Company Details
    Table 92. Bio-Rad Laboratories Business Overview
    Table 93. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product
    Table 94. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 95. Bio-Rad Laboratories Recent Development
    Table 96. Cavidi Company Details
    Table 97. Cavidi Business Overview
    Table 98. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 99. Cavidi Recent Development
    Table 100. Cepheid Company Details
    Table 101. Cepheid Business Overview
    Table 102. Cepheid Infectious Disease Diagnostics Testing Product
    Table 103. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 104. Cepheid Recent Development
    Table 105. Corgenix Company Details
    Table 106. Corgenix Business Overview
    Table 107. Corgenix Infectious Disease Diagnostics Testing Product
    Table 108. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 109. Corgenix Recent Development
    Table 110. Diaxonhit Company Details
    Table 111. Diaxonhit Business Overview
    Table 112. Diaxonhit Infectious Disease Diagnostics Testing Product
    Table 113. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 114. Diaxonhit Recent Development
    Table 115. Eiken Chemical Company Details
    Table 116. Eiken Chemical Business Overview
    Table 117. Eiken Chemical Infectious Disease Diagnostics Testing Product
    Table 118. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 119. Eiken Chemical Recent Development
    Table 120. EMD Millipore Company Details
    Table 121. EMD Millipore Business Overview
    Table 122. EMD Millipore Infectious Disease Diagnostics Testing Product
    Table 123. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 124. EMD Millipore Recent Development
    Table 125. Epitope Diagnostic Company Details
    Table 126. Epitope Diagnostic Business Overview
    Table 127. Epitope Diagnostic Infectious Disease Diagnostics Testing Product
    Table 128. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 129. Epitope Diagnostic Recent Development
    Table 130. EUROIMMUN Company Details
    Table 131. EUROIMMUN Business Overview
    Table 132. EUROIMMUN Infectious Disease Diagnostics Testing Product
    Table 133. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 134. EUROIMMUN Recent Development
    Table 135. Gold Standard Diagnostics Company Details
    Table 136. Gold Standard Diagnostics Business Overview
    Table 137. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product
    Table 138. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 139. Gold Standard Diagnostics Recent Development
    Table 140. Hologic Company Details
    Table 141. Hologic Business Overview
    Table 142. Hologic Infectious Disease Diagnostics Testing Product
    Table 143. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 144. Hologic Recent Development
    Table 145. Immunetics Company Details
    Table 146. Immunetics Business Overview
    Table 147. Immunetics Infectious Disease Diagnostics Testing Product
    Table 148. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 149. Immunetics Recent Development
    Table 150. InBios International Company Details
    Table 151. InBios International Business Overview
    Table 152. InBios International Infectious Disease Diagnostics Testing Product
    Table 153. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2016-2021) & (US$ Million)
    Table 154. InBios International Recent Development
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Diagnostics Testing Market Share by Type: 2020 VS 2027
    Figure 2. Molecular Diagnostic Test Features
    Figure 3. POC Infectious Disease Diagnostics Test Features
    Figure 4. Global Infectious Disease Diagnostics Testing Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Academics Research Case Studies
    Figure 7. Others Case Studies
    Figure 8. Infectious Disease Diagnostics Testing Report Years Considered
    Figure 9. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Infectious Disease Diagnostics Testing Market Share by Regions: 2020 VS 2027
    Figure 12. Global Infectious Disease Diagnostics Testing Market Share by Regions (2022-2027)
    Figure 13. Global Infectious Disease Diagnostics Testing Market Share by Players in 2020
    Figure 14. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Diagnostics Testing as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2020
    Figure 16. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2016-2021)
    Figure 17. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2022-2027)
    Figure 18. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Infectious Disease Diagnostics Testing Market Share by Type (2016-2027)
    Figure 20. North America Infectious Disease Diagnostics Testing Market Share by Application (2016-2027)
    Figure 21. North America Infectious Disease Diagnostics Testing Market Share by Country (2016-2027)
    Figure 22. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Infectious Disease Diagnostics Testing Market Share by Type (2016-2027)
    Figure 26. Europe Infectious Disease Diagnostics Testing Market Share by Application (2016-2027)
    Figure 27. Europe Infectious Disease Diagnostics Testing Market Share by Country (2016-2027)
    Figure 28. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2016-2027)
    Figure 38. China Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Infectious Disease Diagnostics Testing Market Share by Type (2016-2027)
    Figure 46. Latin America Infectious Disease Diagnostics Testing Market Share by Application (2016-2027)
    Figure 47. Latin America Infectious Disease Diagnostics Testing Market Share by Country (2016-2027)
    Figure 48. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Country (2016-2027)
    Figure 54. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Infectious Disease Diagnostics Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 58. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 59. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 60. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 61. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 64. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 65. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 66. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 67. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 68. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 69. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 70. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 71. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 72. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 73. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 74. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 75. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and China Mycobacterium Tuberculosis Antibodies Market Insights Forecast to 2027
Global and China Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15D7777
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Escherichia Coli Antibody Market Insights Forecast to 2027
Global and China Escherichia Coli Antibody Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20G7629
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chlamydia Trachomatis Antibodies Market Insights Forecast to 2027
Global and United States Chlamydia Trachomatis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21F7760
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart